Abstract

Differentiating ulcerative colitis (UC) from Crohn's colitis (CC) can be difficult and may lead to inaccurate diagnoses in up to 30% of inflammatory bowel disease (IBD) patients. Much of the diagnostic uncertainty arises from the overlap of clinical and histologic features. Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) permits a histology-directed cellular protein analysis of tissues. As a pilot study, we evaluated the ability of histology-directed MALDI-MS to determine the proteomic patterns for potential differences between CC and UC specimens. Mucosal and submucosal layers of CC and UC colon resection samples were analyzed after histologic assessment. To determine whether MALDI-MS would distinguish inflammation, the uninflamed (n = 21) versus inflamed submucosa (n = 22) were compared in UC and the uninflamed (n = 17) versus inflamed submucosa (n = 20) in CC. To determine whether there were proteomic differences between the colitides, the uninflamed UC submucosa (n = 21) was compared versus the uninflamed CC submucosa (n = 17), the inflamed UC submucosa (n = 22) was compared versus the inflamed CC submucosa (n = 20), and inflamed UC mucosa versus inflamed CC mucosa. Pairwise statistics comparisons of the subsets were performed. Pairwise comparative analyses of the clinical groups allowed identifying subsets of features important for classification. Comparison of inflamed versus uninflamed CC submucosa showed two significant peaks: m/z 6445 (P = 0.0003) and 12692 (P = 0.003). In the case of inflamed versus uninflamed UC submucosa, several significant differentiating peaks were found, but classification was worse. Comparisons of the proteomic spectra of inflamed submucosa between UC and CC identified two discrete significant peaks: m/z 8773 (P = 0.006) and 9245 (P = 0.0009). Comparisons of the proteomic spectra of uninflamed submucosa between UC and CC identified three discrete significant peaks: m/z 2778 (P = 0.005), 9232 (P = 0.005), and 9519 (P = 0.005). No significantly different features were found between UC and CC inflamed mucosa. MALDI-MS was able to distinguish CC and UC specimens while profiling the colonic submucosa. Further analyses and protein identification of the differential protein peaks may aid in accurately diagnosing IBD and developing appropriate personalized therapies.

Highlights

  • Current therapeutic options for inflammatory colitis, including ulcerative colitis (UC) and Crohn's colitis (CC), involve pharmacologic therapy[1] or surgical resection or both.[2,3] The distinction between CC and UC is of the utmost importance especially when determining the candidacy of a patient for restorative proctocolectomy (RPC)

  • MALDI-MS was able to distinguish CC and UC specimens while profiling the colonic submucosa

  • Further analyses and protein identification of the differential protein peaks may aid in accurately diagnosing inflammatory bowel disease (IBD) and developing appropriate personalized therapies

Read more

Summary

Introduction

Current therapeutic options for inflammatory colitis, including ulcerative colitis (UC) and Crohn's colitis (CC), involve pharmacologic therapy[1] or surgical resection or both.[2,3] The distinction between CC and UC is of the utmost importance especially when determining the candidacy of a patient for restorative proctocolectomy (RPC). Up to 15 percent of UC patients that undergo RPC will have their diagnosis changed to CC based on final pathology or development of Crohn's disease in the ileal pouch.[2,4,5] This diagnostic dilemma and the potential morbidity from an incorrect diagnosis and inappropriate operative therapy underscores the necessity of research efforts aimed at accurate colitis diagnosis.[6,7,8,9] Early diagnostic accuracy of inflammatory colitis will lead to appropriate therapeutic medical options and will aid in determining appropriate candidates for RPC. Differentiating ulcerative colitis (UC) from Crohn's colitis (CC) can be difficult and may lead to inaccurate diagnoses in up to 30 percent of inflammatory bowel disease (IBD) patients. We evaluated the ability of histology-directed MALDI-MS to determine the proteomic patterns for potential differences between CC and UC specimens

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call